Robert M. Myers

Fondatore presso Orbus Therapeutics, Inc.

60 anni

Health Technology

Consumer Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Ernest Mario	M	85	ALZA CORPORATION Orbus Therapeutics, Inc. Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA.	18 anni
Jason D. Levin	M	-	Orbus Therapeutics, Inc. Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA.	-
Patrick Enright	M	62	Orbus Therapeutics, Inc. Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA.	9 anni
Kurt von Emster	M	56	Orbus Therapeutics, Inc. Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA.	4 anni
Terry Gould	M	67	Orbus Therapeutics, Inc. Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA.	9 anni
Alex Zisson	M	54	Orbus Therapeutics, Inc. Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA.	3 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Martin S. Gerstel	M	83	ALZA CORPORATION	25 anni
Geoff Duyk	M	64	EXELIXIS, INC.	7 anni
Jane E. Shaw	M	84	ALZA CORPORATION	24 anni
Deborah Burke	F	-	EXELIXIS, INC.	-
Peter Staple	M	72	ALZA CORPORATION	8 anni
Bruce Cozadd	M	60	ALZA CORPORATION	11 anni
Michael W. Ramsay	M	67	ALZA CORPORATION	2 anni
Christopher Dammann	M	54	ALZA CORPORATION	1 anni
Asha Ramdas	F	-	ALZA CORPORATION	-
Carolyn Feamster	F	-	ALZA CORPORATION	-
Padmanabh P. Bhatt	M	66	ALZA CORPORATION	5 anni
Ronald P. Haak	M	-	ALZA CORPORATION	14 anni
Joel A. Fernandes	M	54	ALZA CORPORATION	3 anni
David Banks	M	-	ALZA CORPORATION	6 anni
Yifan Zhai	M	62	EXELIXIS, INC.	2 anni
Erik D. Wiberg	M	-	ALZA CORPORATION	8 anni
Casey C. Kopczynski	M	62	EXELIXIS, INC.	6 anni
Michael DesJardin	M	66	ALZA CORPORATION	9 anni
Felissa H. Cagan	F	-	ALZA CORPORATION	3 anni
Diane R. Guinta	M	-	ALZA CORPORATION	11 anni
George Tyson	M	-	ALZA CORPORATION	9 anni
Aron M. Knickerbocker	M	54	ALZA CORPORATION	1 anni
Carole Roth	F	-	ALZA CORPORATION	7 anni
Rekha Hemrajani	F	54	EXELIXIS, INC.	8 anni
Jeff Hargroves	M	58	ALZA CORPORATION	3 anni
Suneel Gupta	M	66	ALZA CORPORATION	12 anni
Wally Reiher	M	-	EXELIXIS, INC.	12 anni
An Cloet	F	53	ALZA CORPORATION	1 anni
Valerie Pierce	F	61	ALZA CORPORATION	5 anni
Ed F. Schnipper	M	75	ALZA CORPORATION	4 anni
Jeffrey K. Tobias	M	68	ALZA CORPORATION	1 anni
Susan P. Rinne	F	72	ALZA CORPORATION	11 anni
Steven James	M	66	EXELIXIS, INC.	1 anni
Najafi Behrooz	M	-	EXELIXIS, INC.	7 anni
Michael Miller	M	67	ALZA CORPORATION	4 anni
Detlef F. Albrecht	M	63	ALZA CORPORATION	10 anni
Steven Ketchum	M	59	ALZA CORPORATION	8 anni
Phyllis Gardner	M	73	ALZA CORPORATION	4 anni
Howard Rosen	M	66	ALZA CORPORATION	10 anni
Lupe M. Rivera	F	57	EXELIXIS, INC.	9 anni
Steve Cartt	M	61	ALZA CORPORATION	15 anni
Kimberly Manhard	F	64	EXELIXIS, INC.	1 anni
Joan E. Colligan	F	-	ALZA CORPORATION	4 anni
Barbara Finck	M	77	ALZA CORPORATION	2 anni
Scott T. Shearer	M	59	ALZA CORPORATION	8 anni
Samuel Saks	M	69	ALZA CORPORATION	2 anni
James W. Young	M	79	ALZA CORPORATION	5 anni
James Brown	M	67	ALZA CORPORATION	3 anni
Felix Theeuwes	M	86	ALZA CORPORATION	29 anni
Daniel Swisher	M	61	ALZA CORPORATION	9 anni
Matthew Fust	M	59	ALZA CORPORATION	6 anni
Carol A. Gamble	F	71	ALZA CORPORATION	12 anni
Peter K. Working	M	75	ALZA CORPORATION	2 anni
Krisztina Zsebo	M	68	ALZA CORPORATION	-
Kevin Brodbeck	M	-	ALZA CORPORATION	6 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	61	100.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni